Literature DB >> 346491

Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.

V Souvannavong, A Adam, E Lederer.   

Abstract

We studied the time course of humoral and cellular immunity of guinea pigs injected with the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine (MDP Pasteur, 10 microgram) in Freund incomplete adjuvant; the kinetics were compared with those obtained with Freund complete adjuvant (50 microgram of whole Mycobacterium butyricum). The antibody response to ovalbumin was faster and higher with MDP, but dropped sooner to a low level; the secondary response was, however, again higher for MDP than for Freund complete adjuvant. Cellular immunity, as measured by delayed hypersensitivity, and migration inhibition factor production werepositive for both adjuvants. The same response was followed in animals injected with MDPA, the nonamidated analog of MDP; the same kinetics as for Freund incomplete adjuvant were obtained for the primary response, but the secondary response was stronger and gave a positive delayed hypersensitivity reaction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346491      PMCID: PMC422286          DOI: 10.1128/iai.19.3.966-971.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

2.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

3.  Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers.

Authors:  A Adam; M Devys; V Souvannavong; P Lefrancier; J Choay; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

4.  Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.

Authors:  I Löwy; C Bona; L Chedid
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

6.  The role of mycobacteria and silica in the immunological response of the guinea-pig.

Authors:  P C Wilkinson; R G White
Journal:  Immunology       Date:  1966-09       Impact factor: 7.397

7.  Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis.

Authors:  A Adam; R Ciorbaru; J F Petit; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

8.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

9.  Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine.

Authors:  Y Yamamura; I Azuma; K Sugimura; M Yamawaki; M Uemiya
Journal:  Gan       Date:  1976-12

10.  Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

Authors:  A Tanaka; R Saito; K Sugiyama; I Morisaki; S Kotani
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  4 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

2.  Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

Authors:  H Ohkuni; Y Norose; M Ohta; M Hayama; Y Kimura; M Tsujimoto; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

3.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

4.  A new pattern of spinal-cord demyelination in guinea pigs with acute experimental allergic encephalomyelitis mimicking multiple sclerosis.

Authors:  J Colover
Journal:  Br J Exp Pathol       Date:  1980-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.